The goals of this program are to extend our understanding of the biology and application of dendritic cells (DC) in tumor immunology. In each project there is a fundamental need to define the potential role of DCs in these processes. The role(s) of the imaging core are diverse. In summary we will examine protein uptake, trafficking and expression by dendritic cells, examine dendritic cell trafficking and location within tissue systems, investigate cell-cell interactions between DCs, T-cells, and other effector cells, use histology and quantitative histochemistry to measure specific inflammatory processes. These investigations span the entire resolution spectrum of optical microscopic tools, from low resolution studies of whole tissues, to high resolution observations of subcellular compartments. The Center for Biologic Imaging, in which this core service will be performed, is equipped to perform a continuum of optical methods including all types of light and electron microscopy essential to this program. During the previous funding cycle this core has proven to be an invaluable resource, as is demonstrated by collaborative publication and described in the preliminary data section below. This core has and will continue to be used extensively by all projects. Furthermore the current and future research goals of the program have led to the development of program specific imaging tools and have leveraged the acquisition of large instrumentation grants as well as the construction of imaging tools specifically directed to this program. In the previous submission of this proposal, this core was rated as Superior, with no criticism of core function and utility. As such the changes to this aspect of the proposal are minor. The principal changes are the removal of interactions and preliminary data relating to the two projects that have been removed from the proposal.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA073743-10
Application #
7643416
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
10
Fiscal Year
2008
Total Cost
$148,949
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Macatangay, Bernard J C; Riddler, Sharon A; Wheeler, Nicole D et al. (2016) Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells. J Infect Dis 213:1400-9
Lohmueller, Jason J; Sato, Shuji; Popova, Lana et al. (2016) Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. Sci Rep 6:31740
Keyel, Peter A; Roth, Robyn; Yokoyama, Wayne M et al. (2013) Reduction of streptolysin O (SLO) pore-forming activity enhances inflammasome activation. Toxins (Basel) 5:1105-18
Zhang, Lixin; Vlad, Anda; Milcarek, Christine et al. (2013) Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms. Cancer Immunol Immunother 62:423-35
Sun, Chengqun; Heid, Michelle E; Keyel, Peter A et al. (2013) The second transmembrane domain of P2X7 contributes to dilated pore formation. PLoS One 8:e61886
Kimura, Takashi; McKolanis, John R; Dzubinski, Lynda A et al. (2013) MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) 6:18-26
Miskov-Zivanov, Natasa; Turner, Michael S; Kane, Lawrence P et al. (2013) The duration of T cell stimulation is a critical determinant of cell fate and plasticity. Sci Signal 6:ra97
Keyel, Peter A; Tkacheva, Olga A; Larregina, Adriana T et al. (2012) Coordinate stimulation of macrophages by microparticles and TLR ligands induces foam cell formation. J Immunol 189:4621-9
Cramer, Daniel W; Finn, Olivera J (2011) Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol 23:265-71
Morel, Penelope A; Turner, Michael S (2011) Dendritic cells and the maintenance of self-tolerance. Immunol Res 50:124-9

Showing the most recent 10 out of 90 publications